PA005185-ANT-029: Activin-A Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB, ELISA.BP000061-CYT-035: Recombinant Mouse Beta-Defensin 2 (BD-2) Protein
Source: E. coli-derived.
The specific activity is determined by the ability to chemoattract immature human dendritic cells at a concentration of 10-100 ug/ml.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000061-CYT-571: Recombinant Human Beta-Defensin 2 (BD-2) Protein
Source: E. coli-derived.
The specific activity is determined by the ability to chemoattract human dendritic immature cells at a concentration of 10-100 ug/ml.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000103-CYT-609: Recombinant Human Epiregulin
Source: E. coli-derived.
The ED50 was determined by the dose-dependent stimulation of the proliferation of murine Balb/3T3 cells is < 2.0 ug/ml, corresponding to a specific activity of > 500,000 units/mg.
Purity > 97%, by SDS--PAGE and RP-HPLC.BP000143-CYT-411: Recombinant Mouse IL-19
Source: E. coli-derived.
The biological activity was determined by measuring the dose-dependent activation of STAT3 in human epidermal keratinocytes (HEK2a cells). Significant STAT3 activation is observed with >100 ug/ml corresponding to a Specific Activity of 10,000 IU/mg of recombinant mouse IL-19.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000146-CYT-347: Recombinant Human Interleukin-20 (IL-20) Protein
Source: E. coli-derived.
The Biological Activity was determined by measuring the dose dependent activation of STAT3 in human epidermal keratinocytes (HEKa cells).Significant STAT3 activation is observed with 100 ug/ml of recombinant human IL-20 corresponding to a Specific Activity of 10,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000146-CYT-379: Recombinant Mouse Interleukin-20 (IL-20) Protein
Source: E. coli-derived.
The biological activity was determined by measuring the dose dependent activation of STAT3 in human epidermal keratinocytes (HEK2a cells). Significant STAT3 activation is observed with >100 ug/ml corresponding to a specific activity of 1,000 U/mg of Interleukin-20 recombinant mouse.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000154-CYT-625: Recombinant Human Interleukin 31 (IL-31) Protein
Source: E. coli-derived.
The ED50 was determined by its ability to activate STAT following receptor ligand interaction and found to be <5 ug/ml, corresponding to a specific activity of 200,000 units.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000165-CYT-009: Recombinant Human Interleukin-1 family member 5 (IL1F5) Protein
Source: E. coli-derived.
As measured by its binding ability in a functional ELISA, immobilized IL1F5 at 1 ?/ml (100 ul/well) can bind rHuIL-1 Rrp2/Fc Chimera with a linear range of 0.15-5 ug/ml.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000165-CYT-154: Recombinant Mouse Interleukin-1 family member 5 (IL1F5) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. Measured by its ability to inhibit IL-36a, IL-36b or IL-36g induced IL-6 secretion by NIH-3T3 mouse embryonic fibroblast cells. The ED50 for this effect is typically 0.8-4 ug/ml (corresponding to a specific activity of 250-125 units/mg) in the presence of 15 ug/ml of recombinant mouse IL-36b.
Purity: > 95.0% by SDS-PAGE.